{
    "clinical_study": {
        "@rank": "58723", 
        "arm_group": [
            {
                "arm_group_label": "Experimental", 
                "arm_group_type": "Experimental", 
                "description": "Omeprazole 30mg twice Clarithromycin 500mg twice Amoxicillin 1000mg twice\nfor 10 days"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Tetracycline 500mg four times Omeprazole 30mg twice Bismuth 600mg twice Metronidazole 500mg three times for 10 days"
            }
        ], 
        "brief_summary": {
            "textblock": "Prospective study : Helicobacter pylori eradication therapy in accordance with past\n      antibiotics use."
        }, 
        "brief_title": "Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use", 
        "condition": "Helicobacter Eradication", 
        "detailed_description": {
            "textblock": "Antibiotics resistant is serious problem in helicobacter pylori eradication. Clarithromycin\n      is very important antibiotics in eradication. But clarithromycin resistance is increased.\n      Major cause of clarithromycin resistance is past consumption of macrolide. Thus the\n      investigators propose eradication of macrolide used group bismuth contained four drugs\n      therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Peptic ulcer disease\n\n          -  Gastric MALT lymphoma\n\n          -  Early gastric cancer\n\n          -  Familial history of gastric cancer\n\n          -  Idiopathic iron deficiency\n\n          -  Chronic idiopathic thrombocytopenia\n\n          -  Atrophic gastritis\n\n          -  Helicobacter infected dyspepsia\n\n          -  Long term NSAIDs use\n\n        Exclusion Criteria:\n\n          -  Pregnant\n\n          -  Previous proton pump inhibitor, antibiotics or anticoagulant use within 2 weeks\n\n          -  Previous stomach surgery\n\n          -  Severe ill patients (heart failure, hepatic failure, renal failure, hematologic\n             disorder, severe psychologic or neurologic disorder)\n\n          -  Previous Helicobacter eradication\n\n          -  Allergy for Helicobacter eradication medicine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "440", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01938534", 
            "org_study_id": "AJOU-EIRB-152692"
        }, 
        "intervention": {
            "arm_group_label": [
                "Experimental", 
                "Control"
            ], 
            "intervention_name": "Helicobacter pylori eradication", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 31, 2013", 
        "location": {
            "contact": {
                "email": "lkm5104@ajou.ac.kr", 
                "last_name": "Kee Myung Lee, M.D., Ph.D.", 
                "phone": "82-31-219-6939"
            }, 
            "contact_backup": {
                "email": "mdlsk75@hanmail.net", 
                "last_name": "Sun Gyo Lim, M.D.", 
                "phone": "82-31-219-6939"
            }, 
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "zip": "443-721"
                }, 
                "name": "Ajou University Hospital"
            }, 
            "investigator": {
                "last_name": "Kee Myung Lee, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "lkm5104@ajou.ac.kr", 
            "last_name": "Ki Myung Lee, M.D., Ph.D.", 
            "phone": "82-31-219-6939"
        }, 
        "overall_contact_backup": {
            "email": "mdlsk75@hanmail.net", 
            "last_name": "Sun Gyo Lim, M.D.", 
            "phone": "82-31-219-6939"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Eradication rate of Helicobacter pylori", 
            "safety_issue": "No", 
            "time_frame": "one month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01938534"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ajou University School of Medicine", 
            "investigator_full_name": "Sun Gyo Lim", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ajou University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ajou University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}